Deming regression analysis showed that the IBMP ELISA IgA/IgM/IgG COVID-19 kit has no proportional bias, indicating that this assay is in complete agreement for SARS-CoV-2-positive and -negative samples, as shown by the Bland–Altman plot. This evidence concerns the gene CD79A and COVID-19.